On May 25th 2021, The politicians at the
Danish Parliament agreed on continuing the pilot program for medical cannabis. The program for manufacturing and exporting medical cannabis will be permanent, whereas the program for the Danish patients will be prolonged for another 4 years.
With the extension of the pilot program, the uncertainty about the future of the pilot program is over for Denmark as a prime EU country to further investment in the medicinal cannabis industry, while keeping the strict standard ensuring manufacturing of the highest quality cannabis product for benefit of the patients in Europe.